The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Deep Venous Thrombosis
Abstract
Venous thromboembolism (VTE), manifested as either deep venous thrombosis (DVT) or pulmonary embolism (PE), is an extremely common medical problem, occurring either in isolation or as a complication of other diseases or procedures. Yet, despite its frequency, much remains to be learned regarding the pathogenic mechanisms that initiate VTE, about tailoring its treatment to the individual with her/his specific set of risk factors for recurrence, and about its medical management when associated with specific disease entities, such as cancer. These three topics are addressed in this chapter. In Section I, Drs. López and Conde discuss the mechanisms by which venous thrombi may be initiated on the vessel wall in the absence of anatomically overt vessel wall injury. The authors propose a model whereby tissue factor (TF)–bearing microvesicles that arise from cells of monocyte/macrophage lineage can fuse with activated endothelial cells in regions of vessel activation or inflammation and initiate blood coagulation. Key components of this model include docking of the microvesicles to the stimulated endothelium through P-selectin glycoprotein ligand–1 on their surfaces binding to either P-selectin or E-selectin on the endothelium, and the role of hypoxia during blood stasis in initiating local endothelial activation. Elevations in the levels of TF-bearing microvesicles associated with inflammatory conditions would help to explain the increased risk of thrombosis associated with infections and inflammatory states such as inflammatory bowel disease. In Section II, Dr. Clive Kearon discusses the risk factors for recurrent thrombosis and strategies for determining length of therapy and tailoring specific therapies through risk stratification. Those patients who experience VTE in association with a major reversible risk factor such as surgery are much less likely to experience a recurrence when anticoagulation is discontinued than are patients with a persistent risk factor, such as thrombophilia or cancer unresponsive to therapy. Those with a minor reversible risk factor, such as prolonged air travel, have an intermediate risk of recurrence after discontinuance of anticoagulant therapy. The author provides an algorithm for using risk assessment as a means of determining the length and type of therapy to be used to minimize the rate of recurrence while simultaneously diminishing the risk of bleeding associated with anticoagulation. In Section III, Dr. Agnes Lee updates the topic of VTE associated with malignancy. Patients with cancer make up approximately 20% of those presenting with first time VTE, and the presence of VTE forebodes a much poorer prognosis for patients with cancer, likely because of the morbidity associated with VTE itself and because VTE may herald a more aggressive cancer. Recent evidence indicates that low-molecular weight heparins (LMWHs) improve survival in patients with advanced cancer through mechanisms beyond their effect as anticoagulants. Because of their improved efficacy and safety and potential anti-neoplastic effect, the LMWHs have become the anticoagulants of choice for treating VTE associated with cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Venous Thromboembolism
Geerts, W. H., Pineo, G. F., Heit, J. A., Bergqvist, D., Lassen, M. R., Colwell, C. W., & Ray, J. G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.338s · Cited by 5,895
Prevention of Venous Thromboembolism
Geerts, W. H., Heit, J. A., Clagett, G. P., Pineo, G. F., Colwell, C. W., Anderson, F. A., & Wheeler, H. B. (2001) · Chest · doi:10.1378/chest.119.1_suppl.132s · Cited by 4,373
Lee, A. Y. Y., Levine, M. N., Baker, R. I., Bowden, C., Kakkar, A. K., Prins, M., Rickles, F. R., Julian, J. A., Haley, S., Kovacs, M. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025313 · Cited by 2,534
Self-citationThe Long-Term Clinical Course of Acute Deep Venous Thrombosis
Prandoni, P., Lensing, A. W. A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A. M., Polistena, P., Bernardi, E., & Prins, M. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00001 · Cited by 2,109
Prandoni, P., Lensing, A. W. A., Piccioli, A., Bernardi, E., Simioni, P., Girolami, B., Marchiori, A., Sabbion, P., Prins, M. H., Noventa, F., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0108 · Cited by 1,863
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
Pengo, V., Lensing, A. W. A., Prins, M. H., Marchiori, A., Davidson, B. L., Tiozzo, F., Albanese, P., Biasiolo, A., Pegoraro, C., Iliceto, S., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032274 · Cited by 1,828
Decousus, H., Leizorovicz, A., Parent, F., Page, Y., Tardy, B., Girard, P., Laporte, S., Faivre, R., Charbonnier, B., Barral, F.-G., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380701 · Cited by 1,702
Prognosis of Cancers Associated with Venous Thromboembolism
Sørensen, H. T., Mellemkjær, L., Olsen, J. H., & Baron, J. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432504 · Cited by 1,628
Venous thrombosis: a multicausal disease
Rosendaal, F. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10266-0 · Cited by 1,576
Heit, J. A., Mohr, D. N., Silverstein, M. D., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.761 · Cited by 1,352
Drake, T. A., Morrissey, J. H., & Edgington, T. S. (1989) · Europe PMC (PubMed Central) · Cited by 1,192
(2000) · The Lancet · doi:10.1016/s0140-6736(00)02110-3 · Cited by 1,076
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
Self-citationDuration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer
Bergqvist, D., Agnelli, G., Cohen, A. T., Eldor, A., Nilsson, P. E., Le Moigne-Amrani, A., & Dietrich-Neto, F. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012385 · Cited by 1,052
Natural History of Venous Thromboembolism
Kearon, C. (2003) · Circulation · doi:10.1161/01.cir.0000078464.82671.78 · Cited by 1,048
Self-citationBlood-borne tissue factor: Another view of thrombosis
Giesen, P. L. A., Rauch, U., Bohrmann, B., Kling, D., Roqué, M., Fallon, J. T., Badimon, J. J., Himber, J., Riederer, M. A., & Nemerson, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2311 · Cited by 991
Schulman, S., Rhedin, A.-S., Lindmarker, P., Carlsson, A., Lärfars, G., Nicol, P., Loogna, E., Svensson, E., Ljungberg, B., Walter, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322501 · Cited by 932
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
Ridker, P. M., Goldhaber, S. Z., Danielson, E., Rosenberg, Y., Eby, C. S., Deitcher, S. R., Cushman, M., Moll, S., Kessler, C. M., Elliott, C. G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035029 · Cited by 808
Palabrica, T., Lobb, R., Furie, B. C., Aronovitz, M., Benjamin, C., Hsu, Y.-M., Sajer, S. A., & Furie, B. (1992) · Nature · doi:10.1038/359848a0 · Cited by 808
Meyer, G., Marjanovic, Z., Valcke, J., Lorcerie, B., Gruel, Y., Solal-Celigny, P., Le Maignan, C., Extra, J. M., Cottu, P., & Farge, D. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1729 · Cited by 796
High plasma levels of factor VIII and the risk of recurrent venous thromboembolism
Kyrle, P. A., Minar, E., Hirschl, M., Bialonczyk, C., Stain, M., Schneider, B., Weltermann, A., Speiser, W., Lechner, K., & Eichinger, S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430702 · Cited by 763
Falati, S., Liu, Q., Gross, P., Merrill-Skoloff, G., Chou, J., Vandendries, E., Celi, A., Croce, K., Furie, B. C., & Furie, B. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021868 · Cited by 752
Kearon, C., Ginsberg, J. S., Kovacs, M. J., Anderson, D. R., Wells, P., Julian, J. A., MacKinnon, B., Weitz, J. I., Crowther, M. A., Dolan, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035422 · Cited by 751
Self-citationHutten, B. A., Prins, M. H., Gent, M., Ginsberg, J., Tijssen, J. G. P., & Büller, H. R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3078 · Cited by 748
Venous Thromboembolism and Cancer: Risks and Outcomes
Lee, A. Y. Y., & Levine, M. N. (2003) · Circulation · doi:10.1161/01.cir.0000078466.72504.ac · Cited by 721
Self-citationBaglin, T., Luddington, R., Brown, K., & Baglin, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14111-6 · Cited by 694
Kakkar, A. K., Levine, M. N., Kadziola, Z., Lemoine, N. R., Low, V., Patel, H. K., Rustin, G., Thomas, M., Quigley, M., & Williamson, R. C. N. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.002 · Cited by 650
Hirsh, J., & Hoak, J. (1996) · Circulation · doi:10.1161/01.cir.93.12.2212 · Cited by 635
The Risk of a Diagnosis of Cancer after Primary Deep Venous Thrombosis or Pulmonary Embolism
Sørensen, H. T., Mellemkjær, L., Steffensen, F. H., Olsen, J. H., & Nielsen, G. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804233381701 · Cited by 620
Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis
Agnelli, G., Prandoni, P., Santamaria, M. G., Bagatella, P., Iorio, A., Bazzan, M., Moia, M., Guazzaloca, G., Bertoldi, A., Tomasi, C., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450302 · Cited by 591
Recurrent Venous Thromboembolism After Deep Vein Thrombosis: Incidence and Risk Factors
Hansson, P.-O., Sörbo, J., & Eriksson, H. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.769 · Cited by 590
O'Neill, D. D., Westerman, D. P., & Sacco, W. (1966) · doi:10.21236/ad0635168 · Cited by 566
Residual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism
Prandoni, P., Lensing, A. W. A., Prins, M. H., Bernardi, E., Marchiori, A., Bagatella, P., Frulla, M., Mosena, L., Tormene, D., Piccioli, A., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00008 · Cited by 547
Contrino, J., Hair, G., Kreutzer, D. L., & Rickles, F. R. (1996) · Nature Medicine · doi:10.1038/nm0296-209 · Cited by 539
Venous thromboembolism and cancer
Baron, J. A., Gridley, G., Weiderpass, E., Nyren, O., & Linet, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10018-6 · Cited by 513
Schulman, S., Svenungsson, E., & Granqvist, S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00060-6 · Cited by 497
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease
Lane, D. A., & Grant, P. J. (2000) · Blood · doi:10.1182/blood.v95.5.1517.005k48_1517_1532 · Cited by 495
The Risk of Recurrent Venous Thromboembolism in Men and Women
Kyrle, P. A., Minar, E., Bialonczyk, C., Hirschl, M., Weltermann, A., & Eichinger, S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032959 · Cited by 477
Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein
Bogdanov, V. Y., Balasubramanian, V., Hathcock, J., Vele, O., Lieb, M., & Nemerson, Y. (2003) · Nature Medicine · doi:10.1038/nm841 · Cited by 467
Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran
Schulman, S., Wåhlander, K., Lundström, T., Clason, S. B., & Eriksson, H. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030104 · Cited by 454
Severe Pulmonary Embolism Associated with Air Travel
Lapostolle, F., Surget, V., Borron, S. W., Desmaizières, M., Sordelet, D., Lapandry, C., Cupa, M., & Adnet, F. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010378 · Cited by 445
Pinede, L., Ninet, J., Duhaut, P., Chabaud, S., Demolombe-Rague, S., Durieu, I., Nony, P., Sanson, C., & Boissel, J.-P. (2001) · Circulation · doi:10.1161/01.cir.103.20.2453 · Cited by 408
Extended Oral Anticoagulant Therapy after a First Episode of Pulmonary Embolism
Agnelli, G., Prandoni, P., Becattini, C., Silingardi, M., Taliani, M. R., Miccio, M., Imberti, D., Poggio, R., Ageno, W., Pogliani, E., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-1-200307010-00008 · Cited by 400
McEver, R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616128 · Cited by 391
Fleck, R. A., Rao, L. V. M., Rapaport, S. I., & Varki, N. (1990) · Thrombosis Research · doi:10.1016/0049-3848(90)90148-6 · Cited by 361
Levine, M. N., Hirsh, J., Gent, M., Turpie, A. G., Weitz, J., Ginsberg, J., Geerts, W., LeClerc, J., Neemeh, J., Powers, P., et al. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649783 · Cited by 353
Drake, T. A., Cheng, J., Chang, A. C. K., & Taylor, F. B. (1993) · PubMed Central · Cited by 344
Couban, S., Goodyear, M., Burnell, M., Dolan, S., Wasi, P., Barnes, D., MacLeod, D., Burton, E., Andreou, P., & Anderson, D. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.192 · Cited by 331
D-Dimer Levels and Risk of Recurrent Venous Thromboembolism
Eichinger, S. (2003) · JAMA · doi:10.1001/jama.290.8.1071 · Cited by 327
(1997) · British Journal of Surgery · doi:10.1046/j.1365-2168.1997.d01-3882.x · Cited by 296
Hrachovinová, I., Cambien, B., Hafezi-Moghadam, A., Kappelmayer, J., Camphausen, R. T., Widom, A., Xia, L., Kazazian, H. H., Schaub, R. G., McEver, R. P., et al. (2003) · Nature Medicine · doi:10.1038/nm899 · Cited by 296
den Heijer, M., Willems, H. P. J., Blom, H. J., Gerrits, W. B. J., Cattaneo, M., Eichinger, S., Rosendaal, F. R., & Bos, G. M. J. (2007) · Blood · doi:10.1182/blood-2006-04-014654 · Cited by 282
Palareti, G., Legnani, C., Cosmi, B., Valdré, L., Lunghi, B., Bernardi, F., & Coccheri, S. (2003) · Circulation · doi:10.1161/01.cir.0000079162.69615.0f · Cited by 276
The pathogenesis of a coronary thrombus.
Friedman, M., & den Bovenkamp, G. J. V. (1966) · PubMed Central · Cited by 275
The structure and growth of valve-pocket thrombi in femoral veins
Sevitt, S. (1974) · Journal of Clinical Pathology · doi:10.1136/jcp.27.7.517 · Cited by 243
Comparison of Outcomes after Hospitalization for Deep Venous Thrombosis or Pulmonary Embolism
Murin, S., Romano, P., & White, R. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613230 · Cited by 237
P-selectin and leukocyte microparticles are associated with venous thrombogenesis
Myers, D. D., Hawley, A. E., Farris, D. M., Wrobleski, S. K., Thanaporn, P., Schaub, R. G., Wagner, D. D., Kumar, A., & Wakefield, T. W. (2003) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(03)01033-4 · Cited by 229
Evidence-Based Compression: Prevention of Stasis and Deep Vein Thrombosis
Morris, R. J., & Woodcock, J. P. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000109149.77194.6c · Cited by 221
Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism.
Eichinger, S., Stümpflen, A., Hirschl, M., Bialonczyk, C., Herkner, K. R., STAIN, M., Schneider, B., Pabinger, I., Lechner, K., & Kyrle, P. A. (1998) · PubMed · Cited by 220
Deep venous thrombosis of the legs after strokes. Part I--incidence and predisposing factors.
Warlow, C., Ogston, D., & Douglas, A. S. (1976) · BMJ · doi:10.1136/bmj.1.6019.1178 · Cited by 216
Schulman, S., Sten-Linder, M., Wiman, B., Egberg, N., Johnsson, H., Lindmarker, P., & and the DURAC Trial Study Group (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614554 · Cited by 212
The P O2 in venous valve pockets: Its possible bearing on thrombogenesis
Hamer, J. D., Malone, P. C., & Silver, I. A. (1981) · Journal of British Surgery · doi:10.1002/bjs.1800680308 · Cited by 206
White, R. H., Zhou, H., Kim, J., & Romano, P. S. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.13.2033 · Cited by 195
Ritter, A. (1955) · De Gruyter eBooks · doi:10.1515/9783110881707 · Cited by 193
Piovella, F., Crippa, L., Barone, M., D’Angelo, S. V., Serafini, S., Galli, L., Beltrametti, C., & D’Angelo, A. (2002) · PubMed · Cited by 189
Symptomatic Pulmonary Embolism and the Risk of Recurrent Venous Thromboembolism
Eichinger, S., Weltermann, A., Minar, E., Stain, M., Schönauer, V., Schneider, B., & Kyrle, P. A. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.1.92 · Cited by 168
Tissue factor as a tumor procoagulant
Rao, L. V. M. (1992) · Cancer and Metastasis Reviews · doi:10.1007/bf01307181 · Cited by 151
Kearon, C., Ginsberg, J. S., Anderson, D. R., Kovacs, M. J., Wells, P. S., Julian, J. A., MacKinnon, B., Demers, C., Douketis, J. D., Turpie, A. G. G., et al. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2004.00698.x · Cited by 147
Self-citationVariation in Relative Risk of Venous Thromboembolism in Different Cancers
Thodiyil, P. A., & Kakkar, A. K. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613136 · Cited by 135
Long-Term Management of Patients After Venous Thromboembolism
Kearon, C. (2004) · Circulation · doi:10.1161/01.cir.0000140902.46296.ae · Cited by 121
Self-citationKumar, A. F., Villani, M. P., Patel, U. K., Keith, J. C., & Schaub, R. G. (1999) · Circulation · doi:10.1161/01.cir.99.10.1363 · Cited by 115
Masci, G., Magagnoli, M., Zucali, P. A., Castagna, L., Carnaghi, C., Sarina, B., Pedicini, V., Fallini, M., & Santoro, A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.042 · Cited by 99
Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy
Wakefield, T. W., Strieter, R. M., Schaub, R., Myers, D. D., Prince, M. R., Wrobleski, S. K., Londy, F. J., Kadell, A. M., Brown, S. L., Henke, P. K., et al. (2000) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(00)90162-9 · Cited by 95
Decrease in fibrin content of venous thrombi in selectin-deficient mice
Sullivan, V. V., Hawley, A. E., Farris, D. M., Knipp, B. S., Varga, A. J., Wrobleski, S. K., Thanapron, P., Eagleton, M. J., Myers, D. D., Fowlkes, J. B., et al. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(02)00041-0 · Cited by 79
Precipitating factors in venous thrombosis.
Jc, P., & McLACHLIN, J. (1954) · PubMed · Cited by 71
P-Selectin Antagonism Causes Dose-dependent Venous Thrombosis Inhibition
Schaub, R., Wrobleski, S. K., Londy, F. J., Fex, B. A., Chapman, A., Greenfield, L. J., Wakefield, T. W., & Myers, D. D. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615622 · Cited by 69
On the role of von Willebrand factor in promoting platelet adhesion to fibrin in flowing blood
Endenburg, S. C., Hantgan, R., Blokzijl, L., Lankhof, H., Jerome, W. G., Lewis, J., Sixma, J. J., & de Groot, P. G. (1995) · Blood · doi:10.1182/blood.v86.11.4158.bloodjournal86114158 · Cited by 56
INFLUENCE OF HYPOXIA AND HYPOXIA-REOXYGENATION ON ENDOTHELIAL P-SELECTIN EXPRESSION
Closse, C., Seigneur, M., Renard, M., Pruvost, A., Dumain, P., Belloc, F., & Boisseau, M. (1997) · Thrombosis Research · doi:10.1016/s0049-3848(96)00233-2 · Cited by 50
Regulation of Thrombin Generation at Cell Surfaces
Tracy, P. B. (1988) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1002782 · Cited by 47
KANWAR, S., SMITH, C. W., & Kubes, P. (1998) · Microcirculation · doi:10.1111/j.1549-8719.1998.tb00077.x · Cited by 43
The risk of ipsilateral versus contralateral recurrent deep vein thrombosis in the leg
Lindmarker, P., Schulman, S., & THE DURAC TRIAL STUDY GROUP (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00662.x · Cited by 41
Detection of Circulating Tissue Factor and Factor VII in a Normal Population
Albrecht, S., Kotzsch, M., Siegert, G., Luther, T., Großmann, H., Großer, M., & Müller, M. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650365 · Cited by 41
NENDAZ, M. R., & Perrier, A. (2004) · Revue des Maladies Respiratoires · doi:10.1016/s0761-8425(04)71995-6 · Cited by 40
Agnelli, G., Prandoni, P., Bagatella, P., et al. (2001) · Cited by 4
Cited by
Prevention of Venous Thromboembolism
Geerts, W. H., Pineo, G. F., Heit, J. A., Bergqvist, D., Lassen, M. R., Colwell, C. W., & Ray, J. G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.338s · Cited by 5,895
Chiu, J.-J., & Chien, S. (2011) · Physiological Reviews · doi:10.1152/physrev.00047.2009 · Cited by 2,280
Prevention of VTE in Nonorthopedic Surgical Patients
Gould, M. K., Garcia, D. A., Wren, S. M., Karanicolas, P. J., Arcelus, J. I., Heit, J. A., & Samama, C. M. (2012) · Chest · doi:10.1378/chest.11-2297 · Cited by 2,131
Saposnik, G., Barinagarrementeria, F., Brown, R. D., Bushnell, C. D., Cucchiara, B., Cushman, M., deVeber, G., Ferro, J. M., & Tsai, F. Y. (2011) · Stroke · doi:10.1161/str.0b013e31820a8364 · Cited by 1,970
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Middeldorp, S., Veenstra, D. L., Prabulos, A.-M., & Vandvik, P. O. (2012) · Chest · doi:10.1378/chest.11-2300 · Cited by 1,525
Metadata
- Authors
- López, J. A., Kearon, C., & Lee, A. Y. Y.
- Venue
- Hematology
- Publisher
- American Society of Hematology
- Published
- 2004-01-01
- Volume
- 2004
- Issue
- 1
- Pages
- 439-456
- ISSN
- 1520-4383 (ISSN-L)
- 1520-4391
- OpenAlex
- W2127100580
- Cited by
- 272
- References
- 84
- FWCI
- 14.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.